Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.
Sartorio A, Agosti F, Marazzi N, Maffiuletti NA, Cella SG, Rigamonti AE, Guidetti L, Di Luigi L, Muller EE. Sartorio A, et al. Among authors: di luigi l. Clin Endocrinol (Oxf). 2004 Oct;61(4):487-93. doi: 10.1111/j.1365-2265.2004.02129.x. Clin Endocrinol (Oxf). 2004. PMID: 15473882
Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
Di Luigi L, Rigamonti AE, Agosti F, Mencarelli M, Sgrò P, Marazzi N, Cella SG, Müller EE, Sartorio A. Di Luigi L, et al. Eur J Endocrinol. 2009 May;160(5):753-8. doi: 10.1530/EJE-08-0884. Epub 2009 Mar 3. Eur J Endocrinol. 2009. PMID: 19258430 Clinical Trial.
Growth hormone abuse: methods of detection.
Rigamonti AE, Cella SG, Marazzi N, Di Luigi L, Sartorio A, Müller EE. Rigamonti AE, et al. Among authors: di luigi l. Trends Endocrinol Metab. 2005 May-Jun;16(4):160-6. doi: 10.1016/j.tem.2005.03.009. Trends Endocrinol Metab. 2005. PMID: 15860412 Review.
The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men.
Di Luigi L, Baldari C, Sgrò P, Emerenziani GP, Gallotta MC, Bianchini S, Romanelli F, Pigozzi F, Lenzi A, Guidetti L. Di Luigi L, et al. J Clin Endocrinol Metab. 2008 Sep;93(9):3510-4. doi: 10.1210/jc.2008-0847. Epub 2008 Jun 17. J Clin Endocrinol Metab. 2008. PMID: 18559908 Clinical Trial.
147 results